Avian influenza: PGD template
Patient group direction (PGD) template for the supply of oseltamivir for pre and post exposure prophylaxis of avian influenza (flu) strains.
Documents
Details
This PGD template has been developed for use in incidents involving all strains of avian influenza. The PGD template is to support the supply of oseltamivir for pre and post exposure prophylaxis (PEP) of avian influenza as a public health measure in adults and children aged one year or older. It was developed in November 2024, bringing together the previous PGD templates covering H7N9 and non-H7N9 avian influenza. This new PGD includes doses in line with the latest WHO guidance (September 2024) and expert consensus at UKHSA. It is valid from 1 December 2024 until 30 November 2027.
This PGD template requires further authorisation by a clinical governance or patient safety lead, who has designated responsibility for signing PGDs, so the documents meet legal requirements for PGDs. The PGD is not legal or valid without this local, formal authorisation.
Adoption and governance of the use of this PGD is the responsibility of the authorising commissioning body and providers.
Provider organisations and health professionals should check they are working to the current PGD versions and only work to a legally authorised PGD from their commissioning body.
There is also guidance and algorithms for managing avian influenza incidents in birds.